LabConnect Strengthens Leadership Team with Bill Finger's Appointment as SVP of Global Strategic Services

LabConnect's Leadership Enhancement

In a strategic move aimed at bolstering its leadership, LabConnect has appointed Bill Finger as Senior Vice President of Global Strategic Services, effective September 10, 2025. This appointment marks a significant step for LabConnect as it seeks to reinforce its position in the global diagnostics and clinical research sectors.

Bill Finger comes to LabConnect with a robust background, bringing over 25 years of experience in diagnostics and clinical research. His depth of expertise spans the global laboratory and pharmacy landscape, making him a valuable asset for LabConnect in navigating the complexities of the healthcare industry. Finger's impressive track record as an innovative thinker is well recognized, particularly his capability to devise effective strategies, execute them efficiently, and enhance organizational performance while emphasizing operational excellence.

Most recently, Finger served as the Vice President and General Manager of Pharma Services at Quest Diagnostics. Prior to this role, he held significant leadership positions such as Chief Operating Officer at Interpace Pharma Solutions and Executive Vice President of Precision Medicine and Pharma at Cancer Genetics. His leadership at LabCorp in scientific affairs and biorepository also added to his extensive qualifications.

In his new role at LabConnect, Finger will be responsible for leading the company's Scientific Services, Consulting Services, Data Management, and Functional Service Provider (FSP) teams. His proven experience in diagnostics and clinical research is anticipated to play a pivotal role in advancing LabConnect’s efforts to meet client expectations while delivering innovative solutions.

Wes Wheeler, the CEO of LabConnect, expressed his confidence in Finger's abilities, stating, "Bill's leadership in diagnostic and clinical research is a tremendous asset to LabConnect. His experience will ensure we continue to anticipate client needs, deliver innovative solutions, and reinforce our commitment to operational excellence for our clients around the world."

About LabConnect

LabConnect is a leading provider of Central Laboratory Services, Functional Service Provisioning (FSP), and Scientific Consulting, specializing in analytical and logistically complex studies in fields such as immuno-oncology, cell and gene therapies, and rare diseases. LabConnect's unique capabilities combine cutting-edge technology, access to major and emerging markets, and extensive specialized testing expertise, making it a trusted partner for drug development companies seeking comprehensive laboratory services.

The addition of Bill Finger to the LabConnect team is poised to enhance the company's strategic initiatives and operational excellence, thus enabling LabConnect to continue its mission of delivering exceptional services tailored to the evolving needs of the global healthcare landscape. For more details about LabConnect, visit their website at www.labconnect.com or follow them on LinkedIn for ongoing updates and insights.